MAP3K1

MAP3K1 (mitogen-activated protein kinase kinase kinase 1, also known as MEKK1) is a serine/threonine kinase that functions as an upstream regulator of multiple mitogen-activated protein kinase (MAPK) signaling cascades and integrates cellular responses to stress, cytokines, and growth factors^[1][7]. Mechanistically, MAP3K1 activates the JNK, p38, and, in specific cellular contexts, ERK signaling pathways, thereby influencing cell survival, apoptosis, differentiation, migration, and inflammatory responses^[1][8][2]. In addition to its kinase activity, MAP3K1 acts as a signaling scaffold and participates in the regulation of downstream NF-κB signaling, placing it at a critical intersection between MAPK and inflammatory networks^[7][9]. Disease-associated studies have demonstrated that MAP3K1 contributes to tumor cell survival, apoptosis, motility, and migration, and recurrent genetic alterations of MAP3K1 have been identified across multiple cancer types, particularly in tumors with disrupted stress-response signaling^[3][4]. Compared with other MAP3K family members, MAP3K1 is distinguished by the presence of a unique plant homeodomain (PHD) motif that possesses E3 ubiquitin ligase activity and regulates MAPK pathway activation as well as protein stability through ubiquitin-mediated mechanisms^[5][6]. Experimental studies further show that disruption of MAP3K1 PHD function selectively impairs JNK and p38 activation downstream of growth factor and TGF-β signaling, highlighting a nonredundant regulatory role that differs from related MAP3K isoforms^[6]. For experimental applications, chemical inhibition of MAP3K1-associated signaling networks and genetic perturbation models are widely used to investigate MAPK-dependent apoptosis, inflammatory signaling, stem cell differentiation, and cancer biology^[3][5].